跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CERDELGA eliglustat (as tartrate) 84 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
CERDELGA eliglustat (as tartrate) 84 mg capsule blister pack
Approved
STANDARD
CERDELGA eliglustat (as tartrate) 84 mg capsule blister pack
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
1534ceb22f717590
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1534ceb22f717590
Product Name
CERDELGA eliglustat (as tartrate) 84 mg capsule blister pack
Artg Id
218172
Artg Name
CERDELGA eliglustat (as tartrate) 84 mg capsule blister pack
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2015-02-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/195e8c4ea0b19b0d3e770278be5bca72.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6022014c6df99ca721a248aca4452dff.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
1534ceb22f717590
Type
Standard
Back to TGA Approvals